8-K
Current Report
Celldex Therapeutics, Inc. Filed Acc 0001104659-22-008977
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading tm224432d1_8k.htm…